Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Adial Pharmaceuticals is a clinical-stage biopharmaceutical ...

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder, or AUD, in heavy drinking patients and was recently investigated in the company's ONWARD pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the company's proprietary companion diagnostic genetic test. The company is also developing adenosine analogs for the treatment of pain and other disorder
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
4838 Views
Comment
Sign in to post a comment
    146Followers
    793Following
    771Visitors
    Follow